The Research of the Relationship between the Specific Genetic Single Nucleotide Polymorphisms and Blood Stasis Syndrome of Ischemic Stroke.

Status

Active, not recruiting

Phases

Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR-ONRC-10001069

Enrollment

Unknown

Registered

2010-10-19

Start date

2004-03-23

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

stroke

Interventions

Group of blood stasis syndrome of ischemic stroke:Basic treatment

Group of non-blood stasis syndrome of ischemic str:Basic treatment

Eligibility

Sex/Gender

All

Age

41 Years to 89 Years

Inclusion criteria

Inclusion criteria: 1. Meet with the diagnostic standard of ischemic stroke; 2. Cerebral infarction diagnosed by skull CT or MRI.

Exclusion criteria

Exclusion criteria: 1. TIA; 2. Patients with cerebral embolism derived from Brain tumor, brain trauma, cerebral parasitic diseases, metabolism disorders, rheumatic heart disease, coronary heart disease, atrial fibrillation, etc.; 3. Patients associated with other serious diseases and/or psychiatric patients.

Design outcomes

Primary

Measure	Time frame
The angiotensinogen(AGT) gene M235T polymorphism, apolipoprotein E(APOE) gene polymorphism, methylen;	—

Countries

China

Contacts

Public ContactZhong Wang

zhonw@vip.sina.com+86 010 64014411-3308

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026